Prophylaxis and treatment of hepatitis B in immunocompromised patients
Open Access
- 1 May 2007
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 39 (5) , 397-408
- https://doi.org/10.1016/j.dld.2006.12.017
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategiesAnnals of the Rheumatic Diseases, 2006
- Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine†Hepatology, 2005
- Natural history of chronic hepatitis B in co-infected patientsPublished by Elsevier ,2005
- Virologic response and resistance to adefovir in patients with chronic hepatitis BJournal of Hepatology, 2005
- Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapyGut, 2005
- SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTSJournal of Hepatology, 2005
- Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantationTransplant Immunology, 2004
- Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxisGut, 2004
- Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposureLiver Transplantation, 2003
- EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B13–14 September, 2002Geneva, SwitzerlandJournal of Hepatology, 2003